| MDSC proliferation in the BM and EMH12, 20–23, 48, 91, 95
|
G-CSF, GM-CSF, SCF |
| MDSCs have an impaired differentiation45, 69, 78–80
|
TNF, VEGFA |
| Mobilization of MDSCs can occur from the marrow and sites of EMH23, 175, 182
|
CXCL8, G-CSF, GM-CSF |
| Chemotaxis of MDSCs to an inflammatory or tumor site80, 87, 192
|
CCL2, CXCL12 |
| Organ or tumor arrest of circulating MDSCs12, 126, 129
|
VLA4, C5a |
| Activation of MDSCs resulting in increased enzyme secretion and T-cell suppression183, 184
|
PGE2, LTD4, TLR agonists |
| MDSCs can differentiate into OCs, monocytes, granulocytes, OCs, ECs or DCs68, 103, 111
|
ATRA, Vitamin D |